BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23575475)

  • 21. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
    Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
    J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of UNC5B in bladder cancer cells inhibits proliferation and reduces the volume of transplantation tumors in nude mice.
    Kong C; Zhan B; Piao C; Zhang Z; Zhu Y; Li Q
    BMC Cancer; 2016 Nov; 16(1):892. PubMed ID: 27846823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
    Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
    Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiling the evolution of human metastatic bladder cancer.
    Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; Hampton GM; Theodorescu D
    Cancer Res; 2004 Nov; 64(21):7813-21. PubMed ID: 15520187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Biological Roles of Translation Initiation Factor 3b.
    Feng X; Li J; Liu P
    Int J Biol Sci; 2018; 14(12):1630-1635. PubMed ID: 30416377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.
    Wang L; Wen X; Luan F; Fu T; Gao C; Du H; Guo T; Han J; Huangfu L; Cheng X; Ji J
    Cancer Manag Res; 2019; 11():7877-7891. PubMed ID: 31686906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic initiation factor 3B downregulation suppresses cell proliferation, migration and invasion while it induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer.
    Min J; Chen H
    Int J Clin Exp Pathol; 2019; 12(9):3595-3603. PubMed ID: 31934209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.
    Spilka R; Ernst C; Bergler H; Rainer J; Flechsig S; Vogetseder A; Lederer E; Benesch M; Brunner A; Geley S; Eger A; Bachmann F; Doppler W; Obrist P; Haybaeck J
    Cell Oncol (Dordr); 2014 Aug; 37(4):253-67. PubMed ID: 25070653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer.
    Ren H; Mai G; Liu Y; Xiang R; Yang C; Su W
    Front Oncol; 2021; 11():644156. PubMed ID: 33996561
    [No Abstract]   [Full Text] [Related]  

  • 30. Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer.
    Xiong H; Hu M; Huang H; Gong J; Wu J; Zhang H
    Transl Cancer Res; 2019 Oct; 8(6):2242-2251. PubMed ID: 35116977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EIF3B stabilizes PTGS2 expression by counteracting MDM2-mediated ubiquitination to promote the development and progression of malignant melanoma.
    Fang P; Han Y; Qu Y; Wang X; Zhang Y; Zhang W; Zhang N; Li G; Ma W
    Cancer Sci; 2022 Dec; 113(12):4181-4192. PubMed ID: 36050601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
    Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J
    Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.
    Overdevest JB; Thomas S; Kristiansen G; Hansel DE; Smith SC; Theodorescu D
    Cancer Res; 2011 Jun; 71(11):3802-11. PubMed ID: 21482678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.
    Xu T; Qin L; Zhu Z; Wang X; Liu Y; Fan Y; Zhong S; Wang X; Zhang X; Xia L; Zhang X; Xu C; Shen Z
    Oncotarget; 2016 May; 7(19):27445-57. PubMed ID: 27050274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis.
    Wang Y; Shenouda S; Baranwal S; Rathinam R; Jain P; Bao L; Hazari S; Dash S; Alahari SK
    Mol Cancer; 2011 Jul; 10():84. PubMed ID: 21752283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic Investigation of mRNA
    Jiang M; Lu Y; Duan D; Wang H; Man G; Kang C; Abulimiti K; Li Y
    Dis Markers; 2020; 2020():8833438. PubMed ID: 33273988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation.
    Xu C; Shen Y; Shi Y; Zhang M; Zhou L
    Cancer Cell Int; 2022 Apr; 22(1):161. PubMed ID: 35459206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells.
    Choi YJ; Lee YS; Lee HW; Shim DM; Seo SW
    Bone Joint Res; 2017 Mar; 6(3):186-193. PubMed ID: 28360085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.